1999
DOI: 10.1016/s0021-9150(99)00192-6
|View full text |Cite
|
Sign up to set email alerts
|

Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
38
0
1

Year Published

2004
2004
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(41 citation statements)
references
References 14 publications
2
38
0
1
Order By: Relevance
“…Lipid status and metabolic risk in COPD (Table 5) The increased vascular risk in COPD cannot be attributed to an atherogenic lipid pattern. In COPD patients, lipid levels are comparable with those measured in healthy subjects, with values of lipoprotein(a) and of APO B-100 being even signifi cantly lower (Basili et al 1999).…”
Section: Fimognari Et Alsupporting
confidence: 57%
“…Lipid status and metabolic risk in COPD (Table 5) The increased vascular risk in COPD cannot be attributed to an atherogenic lipid pattern. In COPD patients, lipid levels are comparable with those measured in healthy subjects, with values of lipoprotein(a) and of APO B-100 being even signifi cantly lower (Basili et al 1999).…”
Section: Fimognari Et Alsupporting
confidence: 57%
“…This result differs from the results of some former studies. Basili et al 24 , reported high Apo B and lp(a) hand, Fekete and Mosler levels in female COPD patients. That the results are different might be due to differences in the characteristics of the patient groups.…”
Section: Discussionmentioning
confidence: 96%
“…Ancak ateroskleroz için risk faktörü olan artmış kolesterol ve açlık kan şekeri düzeylerinin KOAH hastaların-da sağlıklı bireylere göre artış göstermediği bildirilmektedir (7,8,22,(31)(32)(33). Basili ve arkadaşları KOAH lı hastalarda lipid seviyelerini sağlıklı bireylere göre anlamlı düşük bulmuşlardır (30).…”
Section: Discussionunclassified